Practical management of hidradenitis suppurativa;Manejo práctico de la hidrosadenitis supurativa

Actas Dermo-Sifiliograficas

Volumn 99, Issue 2, 2008, Pages 101-110

  Pedraz Muñoz, Javier ^a   Dauden E ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Hidradenitis suppurativa; Infliximab; Surgery; Treatment

Indexed keywords

ANTIINFECTIVE AGENT; AZATHIOPRINE; CIMETIDINE; CIPROFLOXACIN; CLINDAMYCIN; CLINDAMYCIN PHOSPHATE; CORTICOSTEROID; CORTICOTROPIN; CYCLOSPORIN; CYPROTERONE ACETATE; DAPSONE; DEXAMETHASONE; DIANE; ERYTHROMYCIN; ETANERCEPT; ETHINYLESTRADIOL; ETRETIN; FINASTERIDE; INFLIXIMAB; ISOTRETINOIN; LEUPRORELIN; METHOTREXATE; METRONIDAZOLE; MINOCYCLINE; PREDNISOLONE; TETRACYCLINE;

APOCRINE GLAND; AXILLA; CARBON DIOXIDE LASER; CLINICAL FEATURE; CLINICAL TRIAL; CLOTHING; CRYOTHERAPY; HAIR FOLLICLE; HUMAN; INGUINAL REGION; OBESITY; PERIANAL GLAND; PERINEUM; PUBERTY; RADIOTHERAPY; REVIEW; RISK FACTOR; SKIN FLAP; SKIN GRAFT; SMOKING; SUPPURATIVE HIDRADENITIS;

EID: 41849121230     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S0001-7310(08)74631-3     Document Type: Article

References (61)

1. Slade DEM, Powell BW, Mortimer PS. Hidradenitis suppurativa: patogenesis and management. Br J Plast Surg. 2003;56:451-61.
2. Jemec GBE, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol. 1996;35:191-4.
3. Wolkenstein P, Loundon A, Barrau K, Auquier P, Revuz J. Quality of Life Group of the French Society of Dermatology. J Am Acad Dermatol. 2007;56:621-3.
4. Jemec GBE. Body weight in hidradenitis suppurativa. En: Marks R, Plewig G, editors. Acne and Related disorders. London: Martin Dunitz; 1989. p. 375-6.
5. Der Werth JM, Williams HC, Raeburn JA. The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol. 2000;142:947-53.
6. Barth JH, Kealey T. Androgen metabolism by isolated human axillary apocrine glands in hidradenitis suppurativa. Br J Dermatol. 1991;125:304-8.
7. Koning A, Lehmann C, Rompel R, Happle R. Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology. 1999;198:261-4.
8. Morgan WP, Leicester G. The role of depilation and deodarants in hidradenitis suppurativa. Br J Surg. 1979;66:853-6.
9. Stellon AJ, Wakeling M. Hidradenitis suppurativa associated with use of oral contraceptives. Br Med J. 1989;298:28-9.
10. Gupta AK, Knowles SR, Gupta MA, Jaunkalns R, Shear NH. Lithium therapy associated with hidradenitis suppurativa: case report and a review of the dermatologic side effects of lithium. J Am Acad Dermatol. 1995;32:382-6.
11. Plewig G, Kligman A. Acne, morphogenesis and treatment. Berlin: Springer; 1975. p. 192.
12. Mortimer PS, Lunniss PJ. Hidradenitis suppurativa. J R Soc Med. 2000;93:420-2.
13. Highet AS, Hay RJ, Roberts SOB. Bacterial infections. En: Champion RH, Burton JL, Ebling FJG, editors. Textbook of dermatology. 5th ed. Oxford: Blackwell Scientific Publications; 1990. p. 953-1031.
14. Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurative, and familial benign pemfigus: Surgical approach. En: Roenigk RK, Roenigk HHJ, editors. Dermatologic surgery. Principles and practice. New York: Marcel Dekker; 1989. p. 717-43.
15. Church JM, Fazio VW, Lavery IC, Oakley JR, Milsom JW. The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohn's disease. Int J Colorectal Dis. 1993;8:117-9.
16. Tsianos EV, Dalekos GN, Tzermias C, Merkouropoulos M, Hatzis J. Hidradenitis suppurativa in Crohn's disease. A further support to this association. J Clin Gastroenterol. 1995;20:151-3.
17. Boer J, Weltevreden EF. Hidradenitis suppurativa or acne inverse. A clinicopathological study of early lesions. Br J Dermatol. 1996;135:721-5.
18. Hurley HJJ. Apocrine glands. New York: McGraw Hill; 1979.
19. Tennant Jr F, Bergeron JR, Stone OJ, Mullins JF. Anemia associated with hidradenitis suppurativa. Arch Dermatol. 1968;98:138-40.
20. Williams ST, Busby RC, DeMuth RJ, Nelson H. Perineal hidradenitis suppurativa: presentation of two unusual complications and a review. Ann Plast Surg. 1991;26:456-62.
21. Lapins J, Ye W, Nyren O, Emtestam L. Incidence of cancer among patients with hidradenitis suppurativa. Arch Dermatol. 2001;137:730-4.
22. Moschella SL. Hidradenitis suppurativa. Complications resulting in death. JAMA. 1966;198:201-3.
23. Vasey FB, Fenske NA, Clement GB, Bridgeford PH, Germain BF, Espinoza LR. Immunological studies of the arthritis of acne conglobata and hidradenitis suppurativa. Clin Exp Rheumatol. 1984;2:309-11.
24. Jemec GBE, Wenelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 1998;39:971-4.
25. Clemmensen OJ. Topical treatment of hidradenitis supurativa with clindamycin. Int J Dermatol. 1983;22:325-8.
26. Boer J, Mirjan JP, Gemert V. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol. 1999;40:73-6.
27. Chow ETY, Mortimer PS. Successful treatment of hidradenitis suppurativa and retroauricular acne with etretinate. Br J Dermatol. 1992;126:415.
28. Banerjee AK. Surgical treatment of hidradenitis suppurativa. Br J Surg. 1992;79:863-6.
29. Mortimer PS, Dawber RPR, Gales MA, Moore RA. A double-blind cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol. 1986;115:263-8.
30. Farrell AM, Randall VA, Vafaee T, Dawber RP. Finasteride as a therapy for hidradenitis suppurativa. Br J Dermatol. 1999;141:1138-9.
31. Buckley DA, Rogers S. Cyclosporin-responsive hidradenitis suppurativa. J R Soc Med. 1995;88:289-90.
32. Jemec GBE. Methotrexate is of limited value in the treatment of hidradenitis suppurativa. Clin Exp Dermatol. 2002;27:528-9.
33. Sullivan TP, Welsh E, Kerdel FA, Burdick AE, Kirsner RS. Infliximab for hidradenitis suppurativa. Br J Dermatol. 2003;149:1046-9.
34. Pedraz J, Daudén E, Pérez-Gala S, Goiriz-Valdés R, Fernández-Peñas P, García-Díez A. Hidrosadenitis supurativa tratada con infliximab. Actas Dermosifiliogr. 2007;98:325-31.
35. Cusack C, Buckley C. Etanercept: effective in the management of hidradenitis suppurativa. Br J Dermatol. 2006;154:726-9.
36. Kaur MR, Lewis HM. Hidradenitis suppurativa treated with dapsone: A case series of five patients. J Dermatolog Treat. 2006;17:211-3.
37. Vickers MA. Opertive management of hidradenitis suppurativa of the scrotum and perineum. J Urol. 1975;114:414-6.
38. Jemec GBE. Effect of localized surgical excisions in hidradenitis suppurativa. J Am Acad Dermatol. 1988;18:1103-7.
39. Brown SC, Kazzazi N, Lord PH. Surgical treatment of perineal hidradenitis suppurativa: with special reference to recognition of the perianal form. Br J Surg. 1986;73:978-80.
40. Morgan WP, Harding KG, Hughes LE. A comparison of skin grafting and healing by granulation, following axillary excision for hidradenitis suppurativa. Ann R Coll Surg Engl. 1983;65:235-6.
41. Elwood ET, Bolitho DG. Negative-pressure dressings in the treatment of hidradenitis suppurativa. Ann Plast Surg. 2001;46:49-51.
42. Soldin MG, Tulley P, Kaplan H, Hudson DA, Grobbelaar AO. Chronic axillary hidradenitis - the efficacy of wide excision and flap coverage. Br J Plast Surg. 2000;53:434-6.
43. Finley EM, Ratz JL. Treatment of hidradenitis suppurativa with carbon dioxide laser excision and second intention healing. J Am Acad Dermatol. 1996;34:465-9.
44. Downs A. Smoothbeam laser treatment may help improve hidradenitis suppurativa but not Hailey-Hailey disease. J Cosmet Laser Ther. 2004;6:163-4.
45. Frohlich D, Baaske D, Glatzel M. Radiotherapy of hidradenitis suppurativa - still valid today? Strahlenther Onkol. 2000;176:286-9.
46. Bong JL, Shalders K, Saihan E. Treatment of persistent painful nodules of hidradenitis suppurativa with cryotherapy. Clin Exp Dermatol. 2003;28:241-4.
47. Bogers JW, Minderhoud Bassie W, Hiukeshoven FJ. A case of hidradenitis suppurativa treated with gonadotropin-releasing hormone agonist and by total abdominal hysterectomy with bilateral salpingo-oophorectomy. Am J Obstet Gynecol. 1992;167:517-8.
48. Camisa C, Sexton C, Friedman C. Treatment of hidradenitis suppurativa with combination hypothalamic-pituitary-ovarian and adrenal suppression. A case report. J Reprod Med. 1989;34:543-6.
49. Kipping HF. How I treat hidradenitis suppurativa. Postgrad Med. 1970;48:291-2.
50. Harrison BJ, Kumar S, Read GF, Edwards CA, Scanlon MF, Hughes LE. Hidradenitis suppurativa: evidence for an endocrine abnormality. Br J Surg. 1985;72:1002-4.
51. Sawers RS, Randall VA, Ebling FJ. Control of hidradenitis suppurativa in women using combined antiandrogen and oestrogen therapy. Br J Dermatol. 1986;115:269-74.
52. Goldsmith PC, Dowd PM. Successful therapy of the follicular occlusion triad in a young woman with high dose oral antiandrogens and minocycline. J R Soc Med. 1993;86:729-30.
53. Rose RF, Goodfield MJ, Clark SM. Treatment of recalcitrant hidradenitis suppurativa with oral ciclosporin. Clin Exp Dermatol. 2006;31:154-5.
54. Usmani N, Clayton TH, Everett S, Goodfield MD. Variable response of hidradenitis suppurativa to infliximab in four patients. Clin Exp Dermatol. 2007;32:204-5.
55. Fardet L, Dupuy A, Kerob D, Levy A, Allez M, Begon E, et al. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients. J Am Acad Dermatol. 2007;56:624-8.
56. Harrison BJ, Mudge M, Hughes LE. Recurrence after surgical treatment of hidradenitis suppurativa. Br Med J (Clin Res Ed). 1987;294:487-9.
57. Parks RW, Parks TG. Pathogenesis, clinical features and management of hidradenitis suppurativa. Ann R Coll Surg Engl. 1997;79:83-9.
58. Ritz JP, Runkel N, Haier J, Buhr HJ. Extent of surgery and recurrence rate of hidradenitis suppurativa. Int J Colorectal Dis. 1998;13:164-8.
59. Knaysi Jr GA, Cosman B, Crikelair GF. Hidradenitis suppurativa. JAMA. 1968;203:19-22.
60. Tanaka A, Hatoko M, Tada H, Kuwahara M, Mashiba K, Yurugi S. Experience with surgical treatment of hidradenitis suppurativa. Ann Plast Surg. 2001;47:636-42.
61. Bailey HR, Snyder MJ. Operative management of hidradenitis suppurativa. Op Tech Gen Surg. 2001;3:117-23.